Walleye Capital’s Medtronic MDT Stock Holding History

Walleye Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.3K	Sell	673 -468,117	-100%	-$44.8M	﹤0.01%	3854
2025 Q4	$45M	Buy	+468,790	New	+$45.5M	0.14%	77
2025 Q3	–	Sell	-19,493	Closed	-$1.79M	–	4869
2025 Q2	$1.7M	Buy	+19,493	New	+$1.65M	0.01%	1649
2025 Q1	–	Sell	-16,909	Closed	-$1.51M	–	4759
2024 Q4	$1.35M	Buy	16,909 +11,375	+206%	+$985K	﹤0.01%	2119
2024 Q3	$498K	Sell	5,534 -46,467	-89%	-$3.91M	﹤0.01%	3303
2024 Q2	$4.09M	Sell	52,001 -143,987	-73%	-$11.8M	0.01%	1444
2024 Q1	$17.1M	Buy	195,988 +155,474	+384%	+$13.3M	0.03%	511
2023 Q4	$3.34M	Sell	40,514 -14,960	-27%	-$1.14M	0.01%	1386
2023 Q3	$4.35M	Buy	+55,474	New	+$4.64M	0.01%	1136
2023 Q1	–	Sell	-14,124	Closed	-$1.15M	–	4200
2022 Q4	$1.1M	Buy	+14,124	New	+$1.14M	0.02%	945
2022 Q1	–	Sell	-81,311	Closed	-$8.41M	–	2463
2021 Q4	$8.41M	Buy	+81,311	New	+$9.42M	0.26%	79
2018 Q3	$285K	Buy	+2,901	New	+$268K	0.13%	183

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's MDT Position: Q1 2026 in Review

Walleye Capital reduced its Medtronic (MDT) stake by 100% in Q1 2026, selling an estimated $44.8M and leaving 673 shares worth $58.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

Walleye Capital first reported a position in MDT in Q3 2018 and has held it in 12 quarters since. The position peaked at $45M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Walleye Capital held 673 shares of Medtronic worth $58.3K as of Q1 2026.
Walleye Capital sold 468,117 Medtronic shares in Q1 2026, an estimated $44.8M.
Medtronic made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3854 holding.
Walleye Capital first reported a position in Medtronic in Q3 2018 and has held it in 12 quarters since.
Walleye Capital's Medtronic position peaked at $45M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.